Abstract
With improved survival of children with cancer, attention has focused on late effects of therapy. Among the most clinically bothersome of these is short stature, seen in children in whom cranial radiation has induced growth hormone (GH) deficiency. Some of these children (notably those with a history of acute lymphocytic leukemia or brain tumor) have been treated with and benefited from supplemental GH.